The U.S. Food & Drug Administration recalled Zantac from U.S. markets on April 1, 2020. The FDA found significant contamination of cancer-causing toxins inside Zantac, which increased the chance of cancer in the stomach, liver, and kidneys. If you had one of these diseases and also took Zantac, you may be entitled to a legal award in your favor.
If you received a cancer diagnosis after taking Zantac or drugs containing Ranitidine, you may be entitled to compensation to help cover the related expenses such as:
- Pain and suffering
- Mental anguish
- Ongoing therapy and counseling
- Lost wages or earning potential
- Medical expenses
You may be able to get financial help from a lawsuit for paying common costs like these if you received a diagnosis of cancer after taking Ranitidine drugs for heartburn. For people with questions like “When was Zantac recalled?,” Pintas & Mullins Law Firm may be able to help.
Pharmaceutical advertisers have a standard of duty to report any relevant health risks associated with their products. Without informed consent, your rights were possibly violated if you took Zantac and later became ill.
Why Zantac Was Recalled
The FDA found that Zantac contained a contaminant called N-nitrosodimethylamine (NDMA) in too high a concentration for safe human consumption. NDMA was found to be widespread across the Zantac product line and in high doses, over 100 times the daily allowable amount. Courts may determine that Zantac should have known about this, and thus you may be entitled to financial compensation if you or a loved one were prescribed Zantac and later became sick.
The FDA also found that NDMA may increase in Zantac over time as it sits on the shelf, especially if exposed to higher temperatures. This was listed as the FDA’s primary rationale in recalling ranitidine products such as those sold by the Zantac brand.
NDMA is a probable carcinogen that is known to the FDA. After conducting a study, the FDA found that drugs based on ranitidine, commercially known as Zantac, were contaminated with NDMA.
The FDA published a report on September 1, 2019, that explained their conclusions about Zantac. According to the findings reached by the FDA, scientists found NDMA contamination in ranitidine medications for heartburn, popularly called Zantac, Zantac 75, or similar.
In this September report, the FDA asked companies to voluntarily recall Zantac and any other ranitidine products on the market, mainly due to the fact that the information was murky, yet over time NDMA concentrations could increase in a product during its shelf life.
Health Risks of Zantac
The FDA found Zantac to be contaminated with NDMA, a likely carcinogen. Scientists warned that NDMA contamination can lead to a number of different health problems, such as:
- Bladder cancer
- Breast cancer
- Stomach cancer
- Lung Cancer
- Ovarian cancer
- Testicular cancer
- Liver disease or cancer
- Pancreatic cancer
- Digestive pain
This is a partial list of health problems associated with ranitidine and does not include all diseases caused by NDMA.
Due to no fault of your own, you possibly suffered injuries from Zantac, and you may be entitled to a legal award or settlement because of this.
For a free legal consultation with a When Was Zantac Recalled? Lawyer serving nationwide, call (800) 635-1144
Guidance for People Who Took Zantac
A lawyer might be able to help you claim a financial award in the legal system due in part to your suffering and expense in fighting diseases linked to Zantac. For example, if you suffered from cancer in the past, and also took Zantac, then you may be entitled to financial compensation.
Zantac and ranitidine products were commonplace in advertising, pharmacies, and markets across the US markets for decades. It was not disclosed to the public that Zantac and similar products might contain a likely carcinogen. If this was known and properly disclosed as a health risk, fewer people would have bought the product. This is why the legal system may be prepared to place the financial burden of your injuries on the defendant, Zantac.
Background on N-Nitrosodimethylamine (NDMA)
NDMA is an environmental contaminant listed by the FDA as a probable carcinogen. NDMA was once used in the production of rocket fuel but was discontinued due to its toxicity as a pollutant.
Presently, NDMA is only produced by scientists specifically to induce tumors in laboratory animals, per the National Library of Medicine.
NDMA has a yellowish color, is odorless, and extremely flammable. NDMA was not found in high amounts when the FDA tested Zantac in the late 1970s and 80s. But in the fall of 2019, shipments all over the US market began testing for very high amounts of NDMA, in some instances over 100 times the safe dosage for daily human consumption.
When Was Zantac Recalled? Lawyer Near Me (800) 635-1144
Getting Legal Help
A jury could determine that Zantac and similar companies should have known about this contamination. If Zantac violated the law in allowing such contamination, you may be able to win a legal award to offset your pain, suffering, and financial costs.
Many people who asked “When was Zantac recalled?” also ended up filing a lawsuit against Zantac. In these numerous lawsuits, the legal system is going to give both sides due process but no verdicts are rendered yet. A lawyer may be able to help if you have more questions.
If you need more clarification about the Zantac recall, Pintas & Mullins Law Firm is looking to help you. Call (800) 635-1144 today for a free consultation.